PlantXBABY logo.jpg
PlantX Launches Baby Products Vertical with Else Nutrition
05 janv. 2021 08h30 HE | PlantX Life, Inc.
VANCOUVER, British Columbia , Jan. 05, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — PlantX Life Inc. (the “Company” or “PlantX”) (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is pleased to announce...
Finally, parents can take research-based classes online on infant, toddler at preschooler care at ParentEducate.com
10 nov. 2020 10h32 HE | ChildCare Education Institute
ATLANTA, GA, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Gone are the days of wondering, “What are my child’s developmental milestones?” and “How do I keep my child safe indoors?.” Starting today, parents...
Conagen Wins SynBioBeta Award for Non-GMO Human Milk Oligosaccharide and Human Lactoferrin
29 sept. 2020 04h00 HE | Conagen
Bedford, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- SynBioBeta’s (SBB) Synthetic Biology Global Conference awarded Conagen the “Best Product of the Year” for its human lactoferrin and non-GMO human...
genexa_children_2019
Genexa Provides Parents Cleaner Medicine Solutions for Infants and Children
05 mars 2019 09h42 HE | Genexa
BEVERLY HILLS, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Mounting scientific evidence is showing that chemicals and toxins used in foods and medicines for preserving, flavoring and packaging may...
Infant Bacterial The
Infant Bacterial Therapeutics offentliggör prospekt i samband med listbytet till Nasdaq Stockholm
04 sept. 2018 10h20 HE | Infant Bacterial Therapeutics AB
Den 30 augusti 2018 meddelade Infant Bacterial Therapeutics AB (publ) ("IBT" eller "Bolaget") att Nasdaq Stockholms bolagskommittée godkände ansökan om upptagande till handel av Bolagets aktier i...
Infant Bacterial The
Infant Bacterial Therapeutics publishes prospectus in connection with the list change to Nasdaq Stockholm
04 sept. 2018 10h20 HE | Infant Bacterial Therapeutics AB
On August 30, 2018, Infant Bacterial Therapeutics AB (publ) (”IBT” or the ”Company”) announced that Nasdaq Stockholm’s Listing Committee had approved the admission of the Company’s shares of series B...
gmi 2018.png
Extracorporeal Membrane Oxygenation Market worth over $357 million by 2024: Global Market Insights, Inc.
03 sept. 2018 03h31 HE | Global Market Insights, Inc
Sellbyville, Delaware, Sept. 03, 2018 (GLOBE NEWSWIRE) -- Global Extracorporeal Membrane Oxygenation Market is poised to surpass USD 357 million by 2024; according to a new research study...
IBT planerar att sta
IBT planerar att starta fas 3 studien under andra halvåret 2018 och kontrakterar CRO
26 juin 2018 02h00 HE | Infant Bacterial Therapeutics AB
IBT har tidigare kommunicerat planen att initiera studien första halvåret 2018. Förberedelserna för studien har tagit något längre än beräknat och företaget planerar nu påbörja studien under andra...
IBT plans to start i
IBT plans to start its phase 3 study in the second half of 2018 and contracts CRO
26 juin 2018 02h00 HE | Infant Bacterial Therapeutics AB
IBT has previously announced its plan to start the phase 3 study in the first half of 2018. Preparations for the study have taken slightly longer than expected and the Company now plans to initiate...
Evolve BioSystems Pa
Evolve BioSystems Partners With King’s College London to Resolve Gut Dysbiosis in C-Section Delivered Infants
01 févr. 2018 08h00 HE | Evolve Biosystems
DAVIS, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Evolve BioSystems, Inc., a leader in advancing infant nutrition and health through restoration of the gut microbiome, announced today a collaboration...